Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in elderly depression with Alzheimer's
NCT00488670Phase 3Terminated
- Sponsor
- University of British Columbia
- Start
- Dec 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by University of British Columbia. Started Dec 2010; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00488670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488670.